Anthrax vaccination immunization program

Information paper. November 10, Paytash C. The learned intermediary doctrine and patient package inserts: a balanced approach to preventing drug-related injury. Stanford Law Rev. Michigan Biological Products Institute. Investigational new drug application for anthrax vaccine adsorbed.

Filed with FDA September 20, Broad WJ, Miller J. Germ defense plan in peril as its flaws are revealed. New York Times. August 7, Deadly relic of the Great War. Geissler E. Biological and Toxin Weapons Today. Oxford, England: Oxford University Press; Tucker J, Sands A. An unlikely threat. Bull Atomic Scientists. Joseph SC. Letter to Friedman MA. March 4, Friedman MA. Letter to Joseph SC. March 13, Accessed February 26, Dept of Defense press briefing, December 15, Accessed March 13, Accessed February 19, Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection.

Alibek K, Handelman S. Nass M. Anthrax vaccine: model of a response to the biological warfare threat.

Infect Dis Clin North Am. US Dept of Defense. Surveillance for adverse events associated with anthrax vaccination—US Department of Defense, — Anthrax vaccine: survey of adverse events. ProMED-mail post. April 30, Centers for Disease Control and Prevention. Bussey E. Anthrax vaccine is safe, US health experts say. July 10, ;Health. Letter to R. Myers director, Michigan Biologics Products Institute. April 28, Form inspectional observations for Bioport Corp.

October 10—26, Bioport Corporation forms strategic alliance with Hollister-Stier Laboratories. PR News. May 29, September 23, Subject: review of anthrax vaccine supplemental test program.

Supplied to the House National Security Subcommittee, Joint Program Office document Presentation to the Institute of Medicine Committee to assess anthrax vaccine safety and efficacy. October 3, Mootrey GT. Publication GAOT. Blanck RR then army surgeon general. December 10, Medical Readiness: Safety and efficacy of the Anthrax Vaccine. Tanner J. Survey of reactions following anthrax vaccination.

Chronic multisymptom illness affecting air force veterans of the Gulf War. DOD's mandatory anthrax vaccine immunization program for military personnel. Early on, some members of the armed forces expressed concern that the vaccine could have health effects. Facing concerns over both the need to protect military personnel against the threat of biological weapons and the fears about the vaccine, in the US Congress directed CDC to develop the AVRP to study the safety of the vaccine and its effectiveness.

In the fall of , the intentional release of B. The event confirmed the urgency of the research and demonstrated the need for studies related to the possible postexposure treatment use of the vaccine. The clinical trial assessed the safety and serological noninferiority of reduced schedules and a comparison of subcutaneous SC and intramuscular IM routes of administration. Jarad M.

Schiffer, Michael M. Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less pdf icon [13 pages].

Expert Review of Vaccines. Quinn et al. Schiffer et al. Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans pdf icon [8 pages] Vaccine.

Site Search. Staff Mission Contact Us. Nov 08, Share this page:. Sign up now». Related News All news. Sep 21 GAO says Defense Department lagging on lab biosecurity. Aug 22 Infectious disease field loses 'commander-in-chief' D. Jul 30 Skip directly to site content Skip directly to page options Skip directly to A-Z link. Vaccines and Preventable Diseases. Section Navigation. Facebook Twitter LinkedIn Syndicate.

Minus Related Pages. On This Page. Pregnancy Considerations. Also Known As. Links with this icon indicate that you are leaving the CDC website.